Sugi Predict

Sugi Predict / Compounds / SCHEMBL6095412

SCHEMBL6095412

SCHEMBL6095412

FC(F)(F)c1ccc(N2CCN(C(Cc3nc4ccccc4[nH]3)c3nc4ccccc4[nH]3)CC2)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ DRD4 P21917 10/20 0.50
▸ NPC1 O15118 1/20 0.47
▸ GAA P10253 1/20 0.47
▸ HTR1A P08908 1/20 0.43
▸ ADRA2C P18825 1/20 0.43
▸ HTR2A P28223 1/20 0.43
▸ LMNA P02545 2/20 0.43
▸ MAPT P10636 2/20 0.43
▸ HTT P42858 2/20 0.43
▸ SMN1; SMN2 Q16637 2/20 0.43
▸ USP2 O75604 1/20 0.43
▸ HSD17B10 Q99714 1/20 0.43
▸ CACNA1G O43497 1/20 0.42
▸ CACNA1B Q00975 1/20 0.42
▸ KCNH2 Q12809 1/20 0.42
▸ GRM2 Q14416 2/20 0.42
▸ MAPK1 P28482 2/20 0.42
▸ ALPL P05186 2/20 0.42
▸ DRD2 P14416 1/20 0.41
▸ DRD3 P35462 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6095538 0.89 DRD4 (0.48) DRD4GAAHTR1AADRA2CHTR2A
SCHEMBL6096282 0.78 DRD4 (0.65) DRD4LMNAMAPTHTTSMN1; SMN2
SCHEMBL6095618 0.72 CACNA1G (0.43) DRD4NPC1GAALMNAMAPT
SCHEMBL6095407 0.72 DRD4 (0.64) DRD4NPC1GAAHTR1AADRA2C
SCHEMBL6874013 0.69 DRD4 (0.56) DRD4NPC1GAAHTR1AADRA2C
SCHEMBL17910658 0.68 TAAR1 (0.53) NPC1LMNASMN1; SMN2MAPK1ALDH1A1
SCHEMBL23964164 0.68 DRD4 (0.68) DRD4NPC1GAAHTR1AADRA2C
SCHEMBL6092577 0.67 PDE10A (0.45) LMNAMAPTHTTSMN1; SMN2MAPK1
SCHEMBL6787298 0.67 DRD4 (1.00) DRD4NPC1GAAHTR1AADRA2C
SCHEMBL7238632 0.66 LMNA (0.46) DRD4LMNAHTTSMN1; SMN2MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7030150-B2 Benzimidazole compounds and antiviral uses thereof TRIMERIS, INC. 2006-04-18 — — US claimed
US-20030119754-A1 Benzimidazole compounds and antiviral uses thereof TRIMERIS, INC. 2003-06-26 — — US claimed
WO-2002092575-A1 BENZIMIDAZOLE COMPOUNDS AND ANTIVIRAL USES THEREOF TRIMERIS, INC. (US) 2002-11-21 — — WO claimed
US-20060142365-A1 Benzimidazole compounds and antiviral uses thereof TRIMERIS, INC. 2006-06-29 — — US disclosed
US-7030150-B2 Benzimidazole compounds and antiviral uses thereof TRIMERIS, INC. 2006-04-18 — — US disclosed
US-20030119754-A1 Benzimidazole compounds and antiviral uses thereof TRIMERIS, INC. 2003-06-26 — — US disclosed
WO-2002092575-A1 BENZIMIDAZOLE COMPOUNDS AND ANTIVIRAL USES THEREOF TRIMERIS, INC. (US) 2002-11-21 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060142365-A1 Benzimidazole compounds and antiviral uses thereof MAVS, ZC3HAV1, TIMM13 DRD4 1827/4885NPC1 1050/4885GAA 199/4885
US-20030119754-A1 Benzimidazole compounds and antiviral uses thereof MAVS, ZC3HAV1, TIMM13 DRD4 1827/4885NPC1 1050/4885GAA 199/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.